Maria Federica Errico

1 publication 2011 – 2011
Antigens, CDBlotting, WesternCell SeparationCaco-2 CellsAC133 Antigen

What does Maria Federica Errico research?

Maria Federica Errico studies the genes related to cancer stem cells in colon cancer. Specifically, she investigates how certain proteins, like CD133, play a role in the activation of genes that are critical for the growth and spread of cancer. By understanding these mechanisms, her research aims to uncover new ways to treat colon cancer, which could improve outcomes for patients by targeting the resistant cancer cells that often lead to relapse.

Key findings

  • Endothelin-1 and NR4A2 genes are more active in colon cancer cells marked by CD133, indicating their role in cancer stem cells.
  • Reducing CD133 in colon cancer cells led to a decrease in the activity of Endothelin-1 and NR4A2, demonstrating their connection.
  • The study highlights potential new strategies for targeting cancer stem cells in colon cancer treatment.

Frequently asked questions

Does Dr. Errico study colon cancer?
Yes, Dr. Errico focuses specifically on the genetic factors involved in colon cancer.
What treatments has Dr. Errico researched?
Her research aims at developing new treatment strategies that target cancer stem cells in colon cancer.
Is Dr. Errico's work relevant to patients with cancer?
Yes, her findings could lead to improved treatment options for patients with colon cancer.

Publications in plain English

Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells.

2011

The Journal of pathology

Puglisi MA, Barba M, Corbi M, Errico MF, Giorda E +7 more

Plain English
This study focused on understanding certain genes linked to cancer stem cells in colon cancer. Researchers found that two genes, Endothelin-1 and NR4A2, were more active in cells marked by CD133, a protein thought to identify these cancer stem cells. When CD133 was reduced in colon cancer cells, the activity of these two genes also decreased, highlighting their connection. This finding is important because it could lead to new strategies for targeting cancer stem cells in colon cancer treatment. Who this helps: This helps patients with colon cancer by potentially leading to improved treatments.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.